Opendata, web and dolomites
H2020 projects about "intestinal"
The page lists 141 projects related to the topic "intestinal".
| # | |||
|---|---|---|---|
| 1 | BIOCYCLE | BIOlogical therapy CYCLEs towards tailored, needs-driven, safer and cost-effective management of Crohn’s disease | 2015 |
| 2 | META-STRESS | Unravelling life-history responses and underlying mechanisms to environmental stress in wild populations | 2015 |
| 3 | CRCStemCellDynamics | Molecular Subtype Specific Stem Cell Dynamics in Developing and Established Colorectal Cancers | 2015 |
| 4 | MARKinPATH | Clinical validation of a bioMARKer for use in INtestinal PATHologies | 2014 |
| 5 | GutILC3 | Cell-cell interactions critical to ILC3 function in the human gut | 2015 |
| 6 | fetISC | Characterizing drivers of intestinal tissue maturation in vitro and in vivo | 2016 |
| 7 | IMSTREV | Immune modulation by lymph node stromal cell-derived extracellular vesicles | 2015 |
| 8 | GUTWORM | Unravelling host intestine-parasite interactions that define immune responses to whipworms | 2015 |
| 9 | BATTLE | The molecular basis of NleB-mediated bacterial virulence | 2016 |
| 10 | DCmucoHIV | HIV/SIV exploits DCs in mucosal infection: mechanisms of transmission and modulation by semen associated factors | 2015 |
| 11 | MUCDIFF | Competition between the enteric pathogen Clostridium difficile and the commensal members of the gut microbiota for mucosal sugars | 2015 |
| 12 | Micropod | MICROPOrous Devices for next-generation therapeutic delivery | 2015 |
| 13 | IPEIBD | Identification of promoters and enhancers specific for inflammatory bowel disease and its subtypes | 2015 |
| 14 | CICCI | Characterization of Intestinal Cancer Cell Invasion | 2015 |
| 15 | Tbet ILC JFN | The role of innate lymphoid cells in regulating intestinal inflammation | 2015 |
| 16 | IntestineUb | The role of Ubiquitin System on the homeostatic control of stem cell maintenance and differentiation in crypt stem cells | 2016 |
| 17 | KCs and Gut Antigens | Elucidating the role of liver resident Kupffer cells in the regulation of the immune responses to intestinal antigens | 2015 |
| 18 | WntTraffic | Characterising the spatial organisation and regulation of the Wnt receptor complex in stem cells and cancer | 2016 |
| 19 | SOX10mutants | Investigating genotype-phenotype correlations in SOX10 neurocristopathies | 2015 |
| 20 | GliaInnateSensing | Glia-derived factors in innate lymphoid cell sensing and intestinal defence | 2015 |
| 21 | IMMUNOBIOME | Identifying microbiotal triggers of inflammatory bowel disease through the lens of the immune system | 2016 |
| 22 | Troy Stem Cells | Troy+ stomach stem cells in homeostasis, repair and pathogenesis | 2015 |
| 23 | WiBEC | Wireless In-Body Environment | 2016 |
| 24 | INTESTINANOS | Intestinal Lipoidal Nanostructures - A Lipid Bridge to Increased Drug Delivery | 2015 |
| 25 | COMIET | Engineering Complex Intestinal Epithelial Tissue Models | 2015 |
| 26 | INTENS | INtestinal Tissue ENgineering Solution | 2016 |
| 27 | Organoid | Dissecting microbiome and immune interactions in human intestinal (cancer) organoids | 2015 |
| 28 | GvHDCure | Understanding the dynamics of the immune system to cure graft-versus-host disease (GvHD). | 2016 |
| 29 | MAST4HEALTH | Mastiha treatment for healthy obese with NAFLD diagnosis (MAST4HEALTH). | 2016 |
| 30 | LIPID IMMUNITY | Regulation of lipid-mediated immunity in the intestine | 2016 |
| 31 | IVSysImmunoProt | Development of an in vitro cellular model to predict the immunological impact of dietary proteins | 2016 |
| 32 | GallBiome | Characterization of the Human Gallbladder Microbiome | 2016 |
| 33 | AB-Prevention | Highly efficient and eco-innovative probiotic food supplement for antibiotic-associated disorders prevention | 2016 |
| 34 | GutBCells | Cellular Dynamics of Intestinal Antibody-Mediated Immune Response | 2016 |
| 35 | AD-gut | Alzheimer Disease - gut connection | 2016 |
| 36 | INVADIS | Microbial invasion and dissemination within the host, mechanisms and effects | 2016 |
| 37 | StemHealth | Foetal Intestinal Stem Cells in Biology and Health | 2016 |
| 38 | CrUCCial | Novel diagnostic and therapeutic approach to inflammatory bowel disease based on functional characterization of patients: the CrUCCial index | 2016 |
| 39 | EMODI | Epithelial resistance modulation to treat disease | 2016 |
| 40 | HDHL-INTIMIC | ERA-Net on INtesTInal MICrobiomics, diet and health, implementing JPI HDHL objectives | 2016 |
| 41 | Diet-namic | From fast food to healthy diet: Addressing the dynamic molecular mechanism of sequential diet switch-induced T cell plasticity for the purpose of developing new treatments for immuno-mediated diseases | 2016 |
| 42 | NEW DEAL | New siRNA Nanotherapy for Inflammatory Bowel Diseases, targeting Janus kinases | 2017 |
| 43 | MUC2GO | THE ROLE OF MUCINS AND MUCUS IN THE DISEASES CYSTIC FIBROSIS, CELIAC DISEASE, AND ULCERATIVE COLITIS | 2016 |
| 44 | EVOMICROCOMM | Evolving interactions in microbial communities | 2017 |
| 45 | TISuMR | Integrated Tissue Slice Culture and NMR Metabolomics – A Novel Approach Towards SystemicUnderstanding of Liver Function And Disease | 2017 |
| 46 | BETA-BACT | Beta-cell inflammation and dysfunction induced by bacterial translocation | 2016 |
| 47 | MODulATE | Gut microbiota-dependent tryptophan metabolism: role in disease pathogenesis and therapeutic target | 2017 |
| 48 | CholeraIndex | Pathoecology of Vibrio cholerae to better understand cholera index cases in endemic areas | 2018 |
| 49 | PANTREAT | Pancreatic cancer as a treatment target of Dwarfbody-Therapeutics | 2017 |
| 50 | FungArth | Role of intestinal fungal communities in arthritic pathology | 2017 |
| 51 | BabyVir | The role of the virome in shaping the gut ecosystem during the first year of life | 2017 |
| 52 | MaRiA | Microbiota and Resolvins in Arthritis | 2017 |
| 53 | MIRA | Characterizing Microbe-specific Immune Responses in the pathogenesis of Autoimmunity | 2017 |
| 54 | ECOSEA | Effects of contaminants on seabirds: an energetics approach | 2017 |
| 55 | MINERVA | MIcrobiota-Gut-BraiN EngineeRed platform to eVAluate intestinal microflora impact on brain functionality | 2017 |
| 56 | LACTOPOC | A Low-cost disposAble eleCTrochemical biOsensor for Point Of Care (POC) hypolactasia diagnostic testing | 2017 |
| 57 | MetaBiota | Crosstalk between microbiota metabolites and immune cells, the missing link to brain damage. | 2017 |
| 58 | TOXANOID | Pharmacological safety testing in human adult stem cell-derived organoids | 2017 |
| 59 | iChip | Intestine-on-a-chip for investigating microbioal-epithelail interaction | 2018 |
| 60 | LIPMETIN-sURFing | Small open reading frames (smORF) as novel modulators of disorders of dietary excess | 2018 |
| 61 | ILCSIGNALLING | Deciphering cell-cell and cell-microbiome interactions of innate lymphoid cells at the single cell level | 2018 |
| 62 | IAPEMIDE | Impact of Intrapartum Antimicrobial Prophylaxis as an early determinant in Microbiome Development | 2017 |
| 63 | GaMePLAY | Gut microbiota impact on brain development and plasticity. | 2017 |
| 64 | FimH-Mech | The molecular mechanism of E. coli FimH pathogenicity | 2017 |
| 65 | MEMORIS | Maternal Enteric Microbiota for Offspring's Repertoire development and Illness Susceptibility | 2018 |
| 66 | DSMT16 | Deciphering causes and consequences of inflammation in subtypes of sporadic intestinal cancer | 2018 |
| 67 | Signalling-in-NODs | Investigation of the role and mechanism of action of NOD2-mediated isoform selective PI3K signalling in gut immunity and inflammation | 2017 |
| 68 | ALLERGUT | Mucosal Tolerance and Allergic Predisposition: Does it all start in the gut? | 2017 |
| 69 | CTC4BMP | Circulating tumor cells for tailoring BMP targeted therapies | 2017 |
| 70 | NeurIMM | Neuroimmune activation as a novel therapeutic approach for IBD | 2017 |
| 71 | SymBreakOrganoid | Cell-to-cell variability during symmetry breaking in organoid development | 2018 |
| 72 | IMBIBE | Innovative technology solutions to explore effects of the microbiome on intestine and brain pathophysiology | 2017 |
| 73 | IntScOmics | A single-cell genomics approach integrating gene expression, lineage, and physical interactions | 2018 |
| 74 | HIT-CF | Personalised Treatment For Cystic Fibrosis Patients With Ultra-rare CFTR Mutations (and beyond) | 2018 |
| 75 | MASTFAST | Rapid production of HUMAN MAST CELLS | 2017 |
| 76 | SysOrganoid | A systems biology approach to investigate cell fate switches in intestinal organoids | 2018 |
| 77 | UTERUS | Unravelling gamma delta T cell emergence and responses in the uterus | 2018 |
| 78 | BESIDE | Bile acids and epithelial stem cells in intestinal development | 2018 |
| 79 | COLONINFO | Improving COLOrectal cancer screening: Novel INverse and FOrward algorithms for a new real-time microwave endoscopy | 2018 |
| 80 | cureCD | Function of long non-coding RNA in Crohn Disease Ulcer Pathogenesis | 2018 |
| 81 | DynaTweezers | DynaTweezers: Elucidating the Molecular Mechanisms of Bacterial Gene Silencing using Tethered Particles and Optical Tweezing | 2018 |
| 82 | SynBioBrain | Building biological computers from bacterial populations | 2018 |
| 83 | MetalloGutRepair | Identification of a Metalloproteinase-17-mediated cellular signalling circuit in intestinal regeneration and tumorigenesis | 2018 |
| 84 | PREMNEC | PReterm Enteroids to determine the Mechanism of Necrotising EnteroColitis | 2018 |
| 85 | EvISC | Infection of the human intestine by enteroviruses: A CRISPR-based screening approach | 2019 |
| 86 | VitC | Structural studies of the full-length human Vitamin C transporters: unravelling Vitamin C transport across the membrane | 2018 |
| 87 | qMAR | Quantification of the intestinal load of a targeted set of resistance genes to Monitor Antibiotic Resistance in paediatric transplant patients | 2018 |
| 88 | MECoCaM | Human gut Microbiome, gene Expression and Colorectal Cancer: Assigning causal roles from a novel Mendelian randomization perspective. | 2018 |
| 89 | Gut-AnorexiaNervosa | Metagenomics and metabolomics studies of patients with Anorexia Nervosa to identify intestinal microbial mechanisms contributing to pathogenesis | 2018 |
| 90 | miVaO | Microbiota mediating Vagal communication in Obesity | 2018 |
| 91 | MDCRC | Metabolic Dynamics in Colorectal Cancer | 2018 |
| 92 | GLIAMAC | Uncovering Enteric GLIA-MACrophage communication in the intestinal homeostasis and inflammation | 2018 |
| 93 | INTEPOL | Elucidating polarity pathways in the fly and murine intestinal epithelium | 2018 |
| 94 | Paget-Advance | Advancing knowledge to improve outcome in Paget’s disease of bone | 2018 |
| 95 | sFilm-FS | Fibrin sealant for anastomotic leaks and haemostasis | 2018 |
| 96 | IntraGutSex | Sex differences in intestinal plasticity | 2018 |
| 97 | ONCOTICS | Probiotics for the Oncological Patients | 2018 |
| 98 | PermeAbility | PermeAbility - A non-invasive, side-effect-free diagnostic kit for intestinal disorders | 2018 |
| 99 | FlexiBiome | Next Generation Microbiome Platform | 2018 |
| 100 | MANNA | Joint Doctorate in Molecular Animal Nutrition | 2018 |
| 101 | GROWTH | Research and Training in Early Life Nutrition to Prevent Disease | 2019 |
| 102 | FlyGutHomeostasis | Identification of paracrine and systemic signals controlling adult stem cell activity and organ homeostasis | 2019 |
| 103 | MicroTher | MicroTher: Drug Discovery from the Microbiota | 2018 |
| 104 | FunHoMic | Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections | 2019 |
| 105 | ONCOBIOME | Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response. | 2019 |
| 106 | VOGAS | Screening of Gastric Cancer via Breath volatile organic compounds by Hybrid Sensing Approach | 2019 |
| 107 | EUPHORIA | Enhancing Ultrasound and PHOtoacoustics for Recognition of Intestinal Abnormalities | 2019 |
| 108 | Fish-AI | Developing an Artificial Intestine for the sustainable farming of healthy fish | 2019 |
| 109 | ARCHEIS | Understanding the onset and impact of Aquatic Resource Consumption in Human Evolution using novel Isotopic tracerS | 2019 |
| 110 | Olfactomics Surgery | BRINGING SURGERY TO THE 21ST CENTURY: REAL-TIME TISSUE ANALYSIS DURING CANCER SURGERY. Improving Patient Safety, Quality and Cost-Effectiveness | 2019 |
| 111 | IDENSTEM | Identification and characterization of enteric nervous system stem cells | 2020 |
| 112 | Neu-i-Gut | Neural regulation of the immune system in the Gut | 2020 |
| 113 | CM_GF | Biological relevance of the multiple infection unit as a novel target for antiviral development | 2020 |
| 114 | RAMEN | RAMan spectroscopy for tracking Exosome based delivery of Nutraceuticals | 2019 |
| 115 | INTERFAT | Elucidating the impact of the microbiome on adipose tissue immune cell interactions during obesity | 2019 |
| 116 | MAGI | Microbial therapy against gut inflammation | 2019 |
| 117 | GUTPOLAR | Membrane trafficking as a link between cell polarity and intestinal absorptive function: from C. elegans to mammalian miniguts | 2019 |
| 118 | SynGut | Molecular, morphological, and functional requirements for gastrointestinal serotonin release | 2020 |
| 119 | RegulatioNFkB | Deciphering transcriptional regulation of NF-kB target genes using integrative omics approaches | 2019 |
| 120 | FUNTRICAN | Functional analysis of thyroid hormone nuclear receptors TRs in human Intestinal Cancer stem cells | 2019 |
| 121 | GLYCO-WAY | Glycomics of Winery Antimicrobial Yeast | 2020 |
| 122 | miR-IBD | Fecal miRNAs, new mediators of host-microbiota interaction in Inflammatory Bowel Disease | 2019 |
| 123 | VASA | Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield® anti-schistosomiasis vaccine in adults in endemic areas of sub-Saharan Africa | 2019 |
| 124 | CeleSte | Commensal microbiota regulation of neuro-immune networks | 2020 |
| 125 | Healthybiota | Microbiota-host interactions for integrative metabolic health reprogramming | 2019 |
| 126 | Retinoic AC-DC | Role of Retinoic Acid signaling in cDC1 and cDC2 on intestinal immune homeostasis and disease | 2020 |
| 127 | PI3K-in-tolerance | PI3K delta role in dendritic cell antigen processing and presentation to control gut tolerance | 2019 |
| 128 | INVADERS | Mucus-Penetrating Microbiota: Characterization, Mechanism and Therapeutic in Metabolic Disease | 2019 |
| 129 | CellSex | The importance of cellular sex in physiology and the underlying mechanisms | 2020 |
| 130 | Obsidian | Obsidian Anastomotic SafeGuard – A powerful and efficient tissue sealant method for reducing the anastomotic leak rate in colorectal surgery | 2019 |
| 131 | IBDetect | Point of Care Diagnostic Test for the Differential Diagnosis of Inflammatory Bowel Disease | 2019 |
| 132 | Bac2MUC | Bacteria-mucin interactions – Shaping intestinal epithelial responses in health and disease | 2020 |
| 133 | ELFO | Electronic Food: enabling edible electronic systems for biomedical and food monitoring applications | 2020 |
| 134 | GUT-SEQ | Single-cell analysis of intestinal lymphocytes reveals targets for treatment of inflammatory bowel disease | 2020 |
| 135 | STRATEGY-CKD | System omics to unravel the gut-kidney axis in Chronic Kidney Disease. | 2020 |
| 136 | REpAIR | Spatio-Temporal Regulation of Inflammation and Tissue Regeneration: Studying the immune system - tissue - microbiota communication to develop targeted therapies for immune-mediated diseases and cancer | 2020 |
| 137 | MicroILCs | "MicroILCs: Deciphering how the gut Microbiota influences Innate Lymphoid Cells in obesity""" | 2021 |
| 138 | MiMoZa | Microbiota modulation through horizontal gene transfer. | 2020 |
| 139 | GUT3D-PLATE | Ready-to-use cell culture plates for gut 3D models | 2020 |
| 140 | GUTMAPS | Cellular cartography of the intestine in health and inflammation | 2021 |
| 141 | MUCO-IMMUN | MUCOBIOME-MEDIATED IMMUNE PATHWAYS IN INFLAMMATORY BOWEL DISEASES | 2020 |